Luzarin, Ericamae .
HRN: 07-88-29 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/03/2025
CEFTRIAXONE 1G (VIAL)
04/03/2025
04/07/2025
IVT
2g
OD
Abortion Incomplete, UTI
Waiting Final Action
Indication: Prophylaxis Type of Infection: Prophylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes